Direct emissions
12,118
tCO2e
Back to search resultsEmissions
Sustainability
Scope
REPORTED REPORTED ESTIMATED ESTIMATED ESTIMATED ESTIMATED ESTIMATED ESTIMATED ESTIMATED ESTIMATED ESTIMATED ESTIMATED ESTIMATED ESTIMATED ESTIMATED ESTIMATED ESTIMATED 
Read the full scoring methodologyOur white paper covers exactly how the Mycelium Score and Transparency Score are calculated, including the normalisation process and what earns a 10/10.Download the white paper (PDF)
Explore carbon emissions data for Solara Active Pharma Sciences Limited. Mycelium helps you review reported emissions, disclosure status, Scope 1, Scope 2 and Scope 3 data, climate targets and sustainability information in one company profile.
This profile brings together available carbon emissions data for Solara Active Pharma Sciences Limited, including reported figures, modelled estimates, disclosure documents and sustainability indicators, so you can review its emissions and compare its performance against similar companies. It is one entry in the Mycelium emissions database. Read how we source and check this data.
Emissions
Carbon emissions
Total yearly emissions across all scopes
76,703tCO2e(Location Based)(Mycelium adjusted)
- Reported by Solara Active Pharma Sciences Limited
- 40,778 tCO₂e
- Estimated by Mycelium
- 35,925 tCO₂e
Solara Active Pharma Sciences Limited reported 53% of the adjusted total. Mycelium estimated the remaining 47% for the categories it did not disclose.
Scope 1
tCO2e
12,118
Scope 2 (Location Based)
tCO2e
28,660
Scope 3 total
tCO2e
35,925
Figures from page 102 of the source report
Scope 3 reported
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
Something wrong? Contribute to this dataset
See the scope breakdownProvenance
Emissions
Factors
0.416kgCO2e / $
Supplier specific emission factors (kgCO2e / $)
Modelled
Reported
UpstreamScope 1, 2 + upstream Scope 3
0.416
0.264
Total+ all Scope 3
–
0.264
Per US dollar of revenue. Mycelium models the upstream factor only.
Which figure should I use?
Estimating your own supply-chain emissions from spend with this company? Use Upstream Modelled. The GHG Protocol defines purchased-goods emissions as cradle-to-gate, which means this company's own operations plus its upstream supply chain. Any of those emissions the company has not disclosed are filled with modelled estimates, so a transparent company is not unfairly penalised against one that simply has not reported.
Looking at what the company filed itself? Use the Reported column. Total Reported also includes downstream emissions, such as the lifetime use of the products this company sells, which the GHG Protocol attributes to the users of those products rather than to customers buying goods and services.
Reported counts only emissions the company has filed itself. A blank or low Reported cell does not mean those emissions do not exist, just that the company has not disclosed them. When Upstream Reported sits close to Upstream Modelled, that is a positive signal: the company has disclosed most of its upstream emissions.
Sustainability
Snapshot
Based on reported data, retrieved with AI
- Solara Active Pharma Sciences Limited reported 40,778 tCO₂e in 2024.
- Scope 2 reported under the location based methodology.
According to available emissions disclosures, Solara Active Pharma Sciences Limited reported total yearly emissions of 40,778 tCO₂e in 2024. Scope 2 emissions accounted for 70% of the reported footprint, indicating purchased energy was the most significant contributor to its carbon footprint.
The company achieved a Mycelium Score of 2.8, placing it below average for its sector for sustainability performance, and received a transparency score of 60.5, meaning they share a fair amount, though with some gaps along the way.
Scope
breakdown
Scope 1 emissions
Direct emissions from sources the company owns or controls, such as fuel use, facilities and vehicles.
Scope 2 emissions
Indirect emissions from purchased energy, including electricity, heating and cooling.
Location based
28,660
tCO2eMarket based
–
tCO2eScope 3 emissions
Wider value chain emissions across the 15 GHG Protocol categories, from purchased goods and business travel to investments, where reported.
Cat 1
Purchased goods & services
11,902
tCO2eCat 2
Capital goods
1,853
tCO2eCat 3
Fuel & energy related activities
5,468
tCO2eCat 4
Upstream transportation & distribution
718
tCO2eCat 5
Waste generated in operations
569
tCO2eCat 6
Business travel
1,444
tCO2eCat 7
Employee commuting
1,452
tCO2eCat 8
Upstream leased assets
184
tCO2eCat 9
Downstream transportation & distribution
686
tCO2eCat 10
Processing of sold products
3,692
tCO2eCat 11
Use of sold products
4,606
tCO2eCat 12
End-of-life treatment of sold products
456
tCO2eCat 13
Downstream leased assets
1,502
tCO2eCat 14
Franchises
549
tCO2eCat 15
Investments
841
tCO2e15 values were derived via Mycelium's normalisation process rather than reported by the company. A cell marked “ESTIMATED” is a figure the company did not disclose, modelled by Mycelium.
Contact Info
Website
solara.co.inCountry
India
Browse carbon emissions data by industry
Jump straight into the sectors users explore most, or view all industries.
How scoring works
How the Mycelium Score is calculated
The Mycelium Score is out of 10. Up to 6.5 points reflect carbon intensity vs peers in the same NACE section (emissions normalised against revenue, log-scaled between the 5th and 95th percentile of each company's latest reporting year in that section; a section needs at least 5 companies to be benchmarked). The band above 6.5 is earned through verified data quality on a claimed profile: declaring every reporting category yourself (up to 2.0), preparation by a carbon accountant (2.0) and independently audited figures (2.0). The total is multiplied by the transparency score and capped at 10. A disclosure with an implausibly large figure (Scope 1 or 2 over 300 million tonnes, a Scope 3 figure over 2 billion tonnes or a total over 2.5 billion tonnes) is not scored until it has been checked.
A higher score means lower carbon intensity than sector peers, backed by data that's third-party verified, claimed by the company, and fully disclosed. Solara Active Pharma Sciences Limited's score sits at the top of this page and in the score panel. Without a revenue figure to measure carbon intensity, or an industry classification to compare it within, a company has no score.
How the Transparency Score is calculated
The Transparency Score is the share of a company's estimated footprint that it reported itself, graded from A (very high) down to F (very low). Where a category is missing, Mycelium models what it would hold for a company of that size and industry and counts it as undisclosed, so an unreported category where the bulk of emissions sit hurts far more than a minor one. Unreported downstream categories (9 to 15) count at a quarter of their modelled size in this share; the carbon intensity behind the score still counts them in full. A Scope 3 total filed without a category breakdown earns very little credit for the part left unattributed, because it does not show which categories are inside it: a company can count business travel, leave purchased goods out entirely, and the total looks the same. Without a revenue figure the footprint cannot be modelled, so the company has no Transparency Score.
For Solara Active Pharma Sciences Limited, the single biggest gap is Purchased goods & services (Scope 3 Category 1). Mycelium estimates it accounts for around 16% of the company's estimated footprint, yet it hasn't been disclosed. Leaving a bucket this large unreported is what's holding the transparency score down.
Other material categories Solara Active Pharma Sciences Limited hasn't disclosed:
- Fuel & energy related activities (Scope 3 Category 3), around 7% of the estimated footprint
- Use of sold products (Scope 3 Category 11), around 6% of the estimated footprint
- Processing of sold products (Scope 3 Category 10), around 5% of the estimated footprint
In total, roughly 47% of Solara Active Pharma Sciences Limited's estimated emissions sit in categories it hasn't reported. Disclosing these would be the fastest way to raise the transparency score.
Read the full scoring methodologyOur white paper covers exactly how the Mycelium Score and Transparency Score are calculated, including the normalisation process and what earns a 10/10.Download the white paper (PDF)Compare Solara Active Pharma Sciences Limited with similar companies
Solara Active Pharma Sciences Limited carbon emissions FAQs
What are Solara Active Pharma Sciences Limited's carbon emissions?
In its 2024 reporting year, Solara Active Pharma Sciences Limited disclosed total emissions of 40,778 tCO2e across all scopes. Including Mycelium estimates for undisclosed categories, the adjusted total is 76,703 tCO2e. Scope 2 accounted for the largest share of the reported total, around 70%.
Does Solara Active Pharma Sciences Limited report Scope 1, Scope 2 and Scope 3 emissions?
For 2024, Solara Active Pharma Sciences Limited's available disclosure covers Scope 1 (12,118 tCO2e) and Scope 2 (28,660 tCO2e). Figures not reported by the company are shown as modelled estimates and labelled as such.
How transparent is Solara Active Pharma Sciences Limited's emissions reporting?
Solara Active Pharma Sciences Limited has a Mycelium transparency score of 60.5 out of 100. The score is the share of the company's estimated footprint that it reported itself, so an undisclosed category where most of its emissions sit weighs far more than a minor one.
Is Solara Active Pharma Sciences Limited sustainable?
Mycelium measures sustainability through carbon emissions data rather than giving a yes or no verdict. Solara Active Pharma Sciences Limited has a Mycelium Score of 2.8 out of 10, which reflects its emissions intensity against sector peers together with how transparent and well-verified its reporting is. The emissions figures and disclosure documents on this page give the fuller picture.
Is Solara Active Pharma Sciences Limited environmentally friendly?
Carbon emissions are one measurable part of environmental impact, and the part Mycelium tracks. Solara Active Pharma Sciences Limited disclosed 40,778 tCO2e for 2024, and its Mycelium Score of 2.8 out of 10 shows how that performance compares with similar companies in its sector.
Learn more about our methodology and where this data comes from.